Pharma Capital

Featured articles

VIEW ALL ARTICLES

Featured companies

Valirx is an international biotechnology cancer focused company, which is in clinical trials a...
Alliance is an international publicly owned pharmaceutical group listed on AIM, part of the Lo...
We are seeking to treat all boys and young men afflicted with the fatal disease Duchenne muscu...
Cynata Therapeutics (ASX:CYP) is listed on the Australian Securities Exchange.
Cancer remains one of the world’s most significant diseases. A key challenge in the fight agai...
WideCells Group PLC is a worldwide healthcare services company focused on collecting and stori...

Executive video interviews

VIEW ALL VIDEOS

Big picture investment ideas in Biotech Capital

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.